Clinical Trial Update: Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of MG in patients with alcoholic fatty liver disease and alcoholic hepatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Fatty Liver Disease
• Alcoholic Hepatitis

Drugs mentioned

• MG

Snippet

Sponsor: PharmaKing | Conditions: Alcoholic Fatty Liver Disease, Alcoholic Hepatitis | Phase 2 | Status: COMPLETED